⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNTM News
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Pomerantz LLP Advises Shareholders of Class Action Against Quantum Biopharma Ltd. – QNTM
accessnewswire.com
QNTM
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Quantum Biopharma Ltd. – QNTM
accessnewswire.com
QNTM
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
QNTM
Pomerantz LLP Advises of Securities Class Action Involving Quantum Biopharma Ltd. – QNTM
accessnewswire.com
QNTM
Pomerantz LLP Advises Shareholders of Class Action Filing Against Quantum Biopharma Ltd. – QNTM
accessnewswire.com
QNTM
Pomerantz LLP Advises of Securities Class Action Against Quantum Biopharma Ltd. – QNTM
accessnewswire.com
QNTM
Pomerantz LLP Advises Shareholders of Class Action Against Quantum Biopharma Ltd. – QNTM
accessnewswire.com
QNTM
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
QNTM
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
QNTM
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM
prnewswire.com
QNTM